Cointime

Download App
iOS & Android

EpimAb Biotherapeutics

company
Funding Round
Series C
Money Raised
$ 120M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
MiraeAsset Financial Group - Yes - Detail
CMB International Capital Corporation - Yes - Detail
Hidragon Capital - - - Detail
Adrian Cheng - - - Detail
Cormorant Asset Management - - - Detail
Decheng Capital - - - Detail
Hony Capital - - - Detail
Octagon Capital Advisors - - - Detail
SDIC Fund Management - - - Detail
Shangbay Capital - - - Detail
Sherpa Venture Capital - - - Detail
Yanchuang Capital - - - Detail

Historical Financing

Announced Date Round Money Raised Investors
Apr 24, 2017 Series A $ 25M 3E Bioventures,Decheng Capital,etc. Detail
Jun 5, 2019 Series B $ 74M SDIC Fund Management,Sherpa Venture Capital,etc. Detail